Back

Select your region

Arrange a consultation about stem cells

Learn more

List of life saving
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
3901 Apheresis Allogeneic Lymphoma Hematology 2021 Standard Therapy Poland 58
3902 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 66
3903 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 57
3904 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 66
3905 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 57
3906 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 63
3907 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 56
3908 Apheresis Autologous Mantle Cell Lymphoma Hematology 2021 Standard Therapy Germany 65
3909 Apheresis Allogeneic Metachromatic Leukodystrophy Hematology 2021 Standard Therapy Poland 60
3910 Apheresis Autologous Morbus Hodgkin Hematology 2021 Standard Therapy Germany 36
3911 Apheresis Autologous Morbus Hodgkin Hematology 2021 Standard Therapy Germany 50
3912 Apheresis Autologous Morbus Hodgkin Hematology 2021 Standard Therapy Germany 21
3913 Apheresis Allogeneic Mucopolysaccharidosis Hematology 2021 Standard Therapy Poland 2
3914 Apheresis Allogeneic Multiple Myeloma Hematology 2021 Standard Therapy Poland 44
3915 Apheresis Allogeneic Multiple Myeloma Hematology 2021 Standard Therapy Poland 60
3916 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 70
3917 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 71
3918 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 53
3919 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 51
3920 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3921 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 65
3922 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 62
3923 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3924 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 66
3925 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 50
3926 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 65
3927 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 50
3928 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 47
3929 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 43
3930 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 66
3931 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 56
3932 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 65
3933 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 51
3934 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3935 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 62
3936 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 68
3937 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 70
3938 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 70
3939 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 38
3940 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3941 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 63
3942 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 71
3943 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 52
3944 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 63
3945 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3946 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 68
3947 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3948 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 58
3949 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3950 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 60
3951 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 58
3952 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 67
3953 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 62
3954 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 42
3955 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 61
3956 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 67
3957 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 57
3958 Apheresis Autologous Multiple Myeloma Hematology 2021 Standard Therapy Germany 68
3959 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 68
3960 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 41
3961 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 60
3962 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 8
3963 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 61
3964 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 62
3965 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 68
3966 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3967 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 56
3968 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 62
3969 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 57
3970 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 47
3971 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3972 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 29
3973 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
3974 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
3975 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
3976 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 59
3977 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 50
3978 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 59
3979 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 28
3980 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 68
3981 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3982 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 54
3983 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
3984 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 52
3985 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
3986 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 75
3987 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 72
3988 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 62
3989 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 40
3990 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 65
3991 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 67
3992 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 72
3993 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 64
3994 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 64
3995 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 53
3996 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 53
3997 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 73
3998 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
3999 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 8
4000 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66